PT-2385

N/A

Report date: 2025/03/28 15:42:04
NME

Base Information

Drug NamePT-2385
Drug Alias NamePT-2385MK-3795
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelial PAS domain-containing protein 1 inhibitors
TargetsEndothelial PAS domain-containing protein 1
Therapy Area/Indicationsvon Hippel-Lindau DiseaseKidney NeoplasmsCarcinoma, Renal Cell +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPeloton Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeloton Therapeutics Inc
Inactive CompaniesN/A
Active Indicationsvon Hippel-Lindau DiseaseKidney NeoplasmsCarcinoma, Renal Cell +[4] 
Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A
Related LinksN/A